Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Stuart Elborn (Belfast, United Kingdom). Oral vs. inhaled antibiotic therapy. International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)

Member's Comments

No comment yet.

Related content which might interest you: Inhaled antibiotic therapy Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections Year: 2013 Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma Source: Eur Respir J, 55 (1) 1901147; 10.1183/13993003.01147-2019 Year: 2020 Co-dispensing of inhaled corticosteroids and antibiotics Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship Source: Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019 Year: 2020 Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007 Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma Source: Annual Congress 2010 - Allergy and risk factors in paediatrics Year: 2010 Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001 Pharmacology of intermittent and continuous inhaled corticosteroid therapy Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use? Year: 2013 Patterns of adherence to inhaled corticosteroids Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Anti-inflammatory therapy COPD: fenspiride and(or) theophylline versus inhaled corticosteroids? Source: Annual Congress 2007 - Treatment of COPD Year: 2007 The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Switching asthma patients using high-dose inhaled steroids to budesonide/formoterol maintenance and reliever therapy Source: Annual Congress 2010 - Management of airway disease Year: 2010 Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006 Inhaled antibiotic therapy in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids Source: Breathe 2010; 6: 365 Year: 2010 Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy Source: Breathe, 17 (4) 210113; 10.1183/20734735.0113-2021 Year: 2021 Efficacy of 12-month treatment with inhaled corticosteroid in bronchiectasis Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003